REFERENCES
1.
Berne RM, Levy MN: The cardiac pump. In
Cardiovascular Physiology, 8th ed. St Louis, CV Mosby, 2001, pp 55–82.
2.
Berne RM, Levy MN: Electrical activity of the heart.
In Cardiovascular Physiology, 8th ed. St Louis,
CV Mosby, 2001, pp 7–32.
3.
Katz AM: The heart as a muscular pump. In
Physiology of the Heart, 3rd ed. Philadelphia, Lippincott-Raven, 2001, pp 408–417.
4.
Takayama Y, Costa KD, Covell JW: Contribution of
laminar myofiber architecture to load-dependent changes in mechanics of LV myocardium.
Am J Physiol Heart Circ Physiol 282:H1510–1520, 2002.
5.
Katz AM: Structure of the heart. In
Physiology of the Heart, 3rd ed. Philadelphia, Lippincott-Raven, 2001, pp 1–38.
6.
Opie LH: Heart cells and organelles. In
The Heart. Physiology from Cell to Circulation, 3rd ed. Philadelphia, Lippincott-Raven,
1998, pp 43–68.
7.
Opie LH: Ventricular function. In
The Heart. Physiology from Cell to Circulation, 3rd ed. Philadelphia, Lippincott-Raven,
1998, pp 343–389.
8.
Frank O: Zur Dynamik des Herzmuskels. Z Biol 32:370,
1895.
9.
Starling EH: Linacre Lecture on the Law of the
Heart. London, Longmans Green, 1918.
10.
Holubarsch C, Ruf T, Goldstein D, et al: Existence
of the Frank-Starling mechanism in the failing human heart. Circulation 94:683–689,
1996.
11.
Katz AM: The working heart. In
Physiology of the Heart, 3rd ed. Philadelphia, Lippincott-Raven, 2001, pp 418–443.
12.
LeWinter MM, Osol G: Normal physiology of the
cardiovascular system. In Fuster V (ed): Hurst's
The Heart, 10th ed. New York, McGraw-Hill, 2001, pp 63–94.
13.
Opie LH: Mechanisms of cardiac contraction and
relaxation. In Braunwald E (ed): Heart Disease,
6th ed. Philadelphia, WB Saunders, 2001, pp 443–478.
14.
Little WC: Assessment of normal and abnormal cardiac
function. In Braunwald E (ed): Heart Disease, 6th
ed. Philadelphia, WB Saunders, 2001, pp 479–502.
15.
Zile MR, Brutsaert DL: New concepts in diastolic
dysfunction and diastolic heart failure. Circulation 105:1387–1393, 2002.
16.
Opie LH: Myocardial contraction and relaxation.
In The Heart. Physiology from Cell to Circulation,
3rd ed. Philadelphia, Lippincott-Raven, 1998, pp 209–231.
17.
Roberts R: Principles of molecular cardiology.
In Fuster V (ed): Hurst's The Heart, 10th ed.
New York, McGraw-Hill, 2001, pp 95–112.
18.
Katz AM: Contractile proteins and cytoskeleton.
In Physiology of the Heart, 3rd ed. Philadelphia,
Lippincott-Raven, 2001, pp 123–150.
19.
Severs NJ: The cardiac muscle cell. Bioessays
22:188–199, 2000.
20.
Yeager M: Structure of cardiac gap junction intercellular
channels. J Struct Biol 121:231–245, 1998.
21.
Severs NJ: Intercellular junctions and the cardiac
intercalated disk. Adv Myocardiol 5:223–242, 1985.
22.
Fill M, Copello JA: Ryanodine receptor calcium
release channels. Physiol Rev 82:893–922, 2002.
23.
Kumar NM, Gilula NB: The gap junction communication
channel. Cell 84:381–388, 1996.
24.
Katz AM: The cardiac action potential. In
Physiology of the Heart, 3rd ed. Philadelphia, Lippincott-Raven, 2001, pp 478–516.
25.
Katz AM: Calcium fluxes. In
Physiology of the Heart, 3rd ed. Philadelphia, Lippincott-Raven, 2001, pp 232–233.
26.
Bers DM: Cardiac excitation-contraction coupling.
Nature 415:198–205, 2002.
27.
de Tombe PP: Cardiac myofilaments: Mechanics
and regulation. J Biomech 36:721–730, 2003.
28.
Opie LH: Excitation-contraction coupling. In
The Heart. Physiology from Cell to Circulation, 3rd ed. Philadelphia, Lippincott-Raven,
1998, pp 149–171.
29.
Bonne G, Carrier L, Richard P, et al: Familial
hypertrophic cardiomyopathy, from mutations to functional defect. Circ Res 83:580–593,
1998.
30.
Solaro RJ, Rarick HM: Troponin and tropomyosin.
Circ Res 83:417–480, 1998.
31.
Fuchs F, Smith SH: Calcium, cross-bridges, and
the Frank-Starling relationship. News Physiol Sci 16:5–10, 2001.
32.
Trinick J, Tskhovrebova L: Titin: A molecular
control freak. Trends Cell Biol 9:377–380, 1999.
33.
Moss RL, Fitzsimons DP: Frank-Starling relationship.
Circ Res 90:11–13, 2002.
34.
Alvarez BV, Perez NG, Ennis IL, et al: Mechanisms
underlying the increase in force and Ca2+
transient that follow stretch
of cardiac muscle. Circ Res 85:716–722, 1999.
35.
Fukuda N, Sasaki D, Ishiwata S, Kurihara S: Length
dependence of tension generation in rat skinned cardiac muscle. Circulation 104:1639–1645,
2001.
36.
Konhilas JP, Irving TC, de Tombe PP: Myofilament
calcium sensitivity in skinned rat cardiac trabeculae. Circ Res 90:59–65,
2002.
37.
Konhilas JP, Irving TC, de Tombe PP: Length-dependent
activation in three striated muscle types of the rat. J Physiol 544:225–236,
2002.
38.
Capetanaki Y: Desmin cytoskeleton: A potential
regulator of muscle mitochondrial behavior and function. Trends Cardiovasc Med 12:339–348,
2002.
39.
Howard J, Hyman AA: Dynamics and mechanics of
the microtubule plus end. Nature 422:753–758, 2003.
40.
Opie LH: Receptors and signal transduction. In
The Heart. Physiology from Cell to Circulation, 3rd ed. Philadelphia, Lippincott-Raven,
1998, p 195.
41.
Rockman HA, Koch WJ, Lefkowitz RJ: Seven-transmembrane-spanning
receptors and heart function. Nature 415:206–212, 2002.
42.
Mendelowitz D: Advances in parasympathetic control
of heart rate and cardiac function. News Physiol Sci 14:155–161, 1999.
43.
Brodde OE, Michel MC: Adrenergic and muscarinic
receptors in the human heart. Pharm Rev 51:651–689, 1999.
44.
Dhein S, Van Koppen CJ, Brodde OE: Muscarinic
receptors in the mammalian heart. Pharm Res 44:161–182, 2001.
45.
Kaumann AJ, Molenaar P: Modulation of human cardiac
function through 4 β-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol
355:667–681, 1997.
46.
Endoh M: Cardiac α1
-adrenoceptors
that regulate contractile function: Subtypes and subcellular signal transduction
mechanisms. Neurochem Res 21:217–229, 1996.
47.
Artega GM, Kobayashi T, Solaro RJ: Molecular actions
of drugs that sensitize cardiac myofilaments to Ca2+
. Ann Med 34:248–258,
2002.
48.
Maisel AS, Scott NA, Motulsky HJ, et al: Elevation
of plasma neuropeptide Y levels in congestive heart failure. Am J Med 86:43–48,
1989.
49.
Grundemar L, Hakanson R: Multiple neuropeptide
Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms.
Gen Pharmacol 24:785–796, 1993.
50.
Henning RJ, Sawmiller DR: Vasoactive intestinal
peptide: Cardiovascular effects. Cardiovasc Res 49:27–37, 2001.
51.
de Bold AJ, Bruneau BG, Kuroski de Bold M: Mechanical
and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 31:7–18,
1996.
52.
Cameron VA, Ellmers LJ: Minireview: Natriuretic
peptides during development of the fetal heart and circulation. Endocrinology 144:2191–2194,
2003.
53.
Delcayre C, Silvestre JS: Aldosterone and the
heart: Towards a physiological function? Cardiovasc Res 42:7–12, 1999.
54.
Martinez A: Biology of adrenomedullin. Microsc
Res Tech 57:1–2, 2002.
55.
Schuijt MP, Jan Danser AH: Cardiac angiotensin
II: An intracrine hormone? Am J Hypertens 15:1109–1116, 2002.
56.
Dinh DT, Frauman AG, Johnston CI, Fabiani ME:
Angiotensin receptors: Distribution, signalling and function. Clin Sci 100:481–492,
2001.
57.
Kitamura K, Kangawa K, Eto T: Adrenomedullin and
PAMP: Discovery, structures, and cardiovascular functions. Microsc Res Tech 57:3–13,
2002.
58.
Minamino N, Kikumoto K, Isumi Y: Regulation of
adrenomedullin expression and release. Microsc Res Tech 57:28–39, 2002.
59.
Smith DM, Coppock HA, Withers DJ, et al: Adrenomedullin:
Receptor and signal transduction. Biochem Soc Trans 30:432–437, 2002.
60.
Opie LH, Sack MN: Enhanced angiotensin II activity
in heart failure. Circ Res 88:654–658, 2001.
61.
De Mello WC: Cardiac arrhythmias: The possible
role of the renin-angiotensin system. J Mol Med 79:103–108, 2001.
62.
Kramer BK, Ittner KP, Beyer ME, et al: Circulatory
and myocardial effects of endothelin. J Mol Med 75:886–890, 1997.
63.
Walker BR, Childs ME, Adamas EM: Direct cardiac
effects of vasopressin: Role of V1
and V2
vasopressinergic
receptors. Am J Physiol 255:H261–H265, 1988.
64.
Chandrashekhar Y, Prahash AJ, Sen A, et al: The
role of arginine vasopressin and its receptors in the normal and failing rat heart.
J Mol Cell Cardiol 35:495–504, 2003.
65.
Parlow JL, Bégou G, Sagnard P, et al: Cardiac
baroreflex during the postoperative period in patients with hypertension. Anesthesiology
90:681–692, 1999.
66.
Campagna JA, Carter C: Clinical relevance of the
Bezold-Jarisch reflex. Anesthesiology 98:1250–1260, 2003.
67.
Huikuri HV, Pikkujamsa SM, Airaksinen KE, et al:
Sex-related differences in autonomic modulation of heart rate in middle-aged subjects.
Circulation 94:122–125, 1996.
68.
Keyl C, Schneider A, Hobbhan, et al: Sinusoidal
neck suction for evaluation of baroreflex sensitivity during desflurane and sevoflurane
anesthesia. Anesth Analg 95:1629–1636, 2002.
69.
Devlin MG, Angus JA, Wilson KM, et al: Acute effects
of L- and T-type calcium channel antagonists on cardiovascular reflexes in conscious
rabbits. Clin Exp Pharmacol Physiol 29:372–380, 2002.
70.
Thomas CJ, Woods RL: Guanylyl cyclase receptors
mediate cardiopulmonary vagal reflex actions of ANP. Hypertension 41:279–285,
2003.
